Trade Tandem Diabetes Care Inc - TNDM CFD
Add to favourite- Summary
- Historical Data
Spread | 0.14 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 40.97 |
Open | 40.39 |
1-Year Change | 72.02% |
Day's Range | 40.08 - 42.97 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Sep 10, 2024 | 40.97 | -1.24 | -2.94% | 42.21 | 42.21 | 39.46 |
Sep 9, 2024 | 42.20 | -0.52 | -1.22% | 42.72 | 43.52 | 41.82 |
Sep 6, 2024 | 42.37 | -0.35 | -0.82% | 42.72 | 43.11 | 41.03 |
Sep 5, 2024 | 42.71 | 2.08 | 5.12% | 40.63 | 43.96 | 40.41 |
Sep 4, 2024 | 41.04 | -0.43 | -1.04% | 41.47 | 41.95 | 40.77 |
Sep 3, 2024 | 41.72 | -1.06 | -2.48% | 42.78 | 43.15 | 41.45 |
Aug 30, 2024 | 43.43 | -0.52 | -1.18% | 43.95 | 45.77 | 42.77 |
Aug 29, 2024 | 44.15 | -0.37 | -0.83% | 44.52 | 45.69 | 43.51 |
Aug 28, 2024 | 44.29 | -0.17 | -0.38% | 44.46 | 45.53 | 44.15 |
Aug 27, 2024 | 45.53 | 1.57 | 3.57% | 43.96 | 46.07 | 43.05 |
Aug 26, 2024 | 44.26 | -0.33 | -0.74% | 44.59 | 45.51 | 43.86 |
Aug 23, 2024 | 44.52 | 1.96 | 4.61% | 42.56 | 44.90 | 42.54 |
Aug 22, 2024 | 42.46 | -0.51 | -1.19% | 42.97 | 43.49 | 41.53 |
Aug 21, 2024 | 42.68 | 0.62 | 1.47% | 42.06 | 43.14 | 41.20 |
Aug 20, 2024 | 41.89 | -1.86 | -4.25% | 43.75 | 44.46 | 41.69 |
Aug 19, 2024 | 45.66 | 1.52 | 3.44% | 44.14 | 46.33 | 44.03 |
Aug 16, 2024 | 44.60 | 1.11 | 2.55% | 43.49 | 44.74 | 43.49 |
Aug 15, 2024 | 43.78 | 2.06 | 4.94% | 41.72 | 44.79 | 41.72 |
Aug 14, 2024 | 41.64 | 0.07 | 0.17% | 41.57 | 41.84 | 40.89 |
Aug 13, 2024 | 41.57 | 3.07 | 7.97% | 38.50 | 42.37 | 38.50 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Tandem Diabetes Care, Inc. Company profile
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company''s flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump''s software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. Its products in development include t:sport insulin delivery system; and connected (mobile) health offerings. Tandem Diabetes Care, Inc. has a development and commercialization agreement with Dexcom, Inc. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.Industry: | Medical Equipment, Supplies & Distribution (NEC) |
12400 High Bluff Drive
SAN DIEGO
CALIFORNIA 92130
US
News
ECB Preview: cuts expected but the pace is uncertain
Markets expect the ECB to cut rates again in September, but how many more?
12:34, 11 September 2024Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com